Wolverine Trading, LLC Grifols Sa Call Options Transaction History

Wolverine Trading, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	SELL	$6.27 - $7.7 $58,310 - $71,610	-9,300 Reduced 19.46%	38,500 $242,000
Q1 2024 May 15, 2024	BUY	$5.47 - $11.38 $261,466 - $543,964	47,800 New	47,800 $319,000
Q2 2023 Aug 23, 2023	SELL	$7.14 - $9.29 $20,706 - $26,940	-2,900 Reduced 13.06%	19,300 $176,000
Q1 2023 May 15, 2023	BUY	$6.65 - $10.69 $147,630 - $237,318	22,200 New	22,200 $166,000
Q4 2021 Feb 14, 2022	SELL	$10.21 - $15.27 $154,171 - $230,577	-15,100 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$14.07 - $17.3 $212,457 - $261,230	15,100 New	15,100 $225,000

164

140M

288K

389K

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $5.33B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.